{"public_id":"cl_4098074fb8962a161ad94c22cb1b686e","status":"active","superseded_by_public_id":null,"corpus_id":9250770,"text":"Non-vaccine serotypes not covered by the 13-valent pneumococcal conjugate vaccine continued to increase in 2012–2014, with serotypes 8 and 22F emerging as the most important.","confidence":0.85,"paper":{"corpus_id":9250770,"title":"Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012–2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes","url":"https://sah.borca.ai/papers/9250770"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.85,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_20922b1ff6589d7371f494f339274948","name":"serotype 8","description":"A pneumococcal capsular serotype not covered by PCV13 that emerged as a frequent cause of adult invasive pneumococcal disease.","types":["serotype"],"url":"https://sah.borca.ai/concepts/co_20922b1ff6589d7371f494f339274948"},{"public_id":"co_4cfcf657d32fccb72e395d6cdd6ef619","name":"13-valent pneumococcal conjugate vaccine","description":"A pneumococcal conjugate vaccine covering 13 serotypes that replaced the 7-valent vaccine as the leading vaccine used in children since 2010.","types":["vaccine"],"url":"https://sah.borca.ai/concepts/co_4cfcf657d32fccb72e395d6cdd6ef619"},{"public_id":"co_f13c0f22369d423f9286b4300c0d90cd","name":"serotype 22F","description":"A pneumococcal capsular serotype not covered by PCV13 that emerged as a frequent cause of adult invasive pneumococcal disease.","types":["serotype"],"url":"https://sah.borca.ai/concepts/co_f13c0f22369d423f9286b4300c0d90cd"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_4098074fb8962a161ad94c22cb1b686e"}